BeiGene (BGNE)
(Delayed Data from NSDQ)
$198.50 USD
+0.34 (0.17%)
Updated Aug 29, 2024 04:00 PM ET
After-Market: $198.56 +0.06 (0.03%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Balance Sheet
Fiscal Year End for BeiGene, Ltd falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 3,186 | 4,535 | 6,618 | 4,651 | 983 |
Receivables | 358 | 173 | 483 | 60 | 71 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 416 | 282 | 243 | 89 | 29 |
Other Current Assets | 243 | 217 | 270 | 160 | 90 |
Total Current Assets | 4,203 | 5,207 | 7,614 | 4,961 | 1,173 |
Net Property & Equipment | 1,324 | 846 | 588 | 358 | 242 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 110 | 66 | 38 |
Intangibles | 57 | 41 | 47 | 5 | 6 |
Deposits & Other Assets | 125 | 176 | 170 | 121 | 71 |
Total Assets | 5,805 | 6,379 | 8,646 | 5,601 | 1,612 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 329 | 428 | 335 | 0 |
Accounts Payable | 315 | 295 | 262 | 232 | 122 |
Current Portion Long-Term Debt | 688 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 694 | 467 | 558 | 346 | 164 |
Income Taxes Payable | 23 | 25 | 21 | 20 | 13 |
Other Current Liabilities | 68 | 328 | 308 | 128 | 0 |
Total Current Liabilities | 1,810 | 1,469 | 1,600 | 1,075 | 310 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 17 | 58 | 234 | 11 | 11 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 198 | 209 | 202 | 184 | 241 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 221 | 226 | 324 | 432 | 47 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,268 | 1,996 | 2,403 | 1,732 | 634 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 11,599 | 11,541 | 11,191 | 7,415 | 2,926 |
Retained Earnings | -7,962 | -7,080 | -4,966 | -3,553 | -1,956 |
Other Equity | -99 | -77 | 18 | 7 | 8 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3,537 | 4,383 | 6,243 | 3,869 | 978 |
Total Liabilities & Shareholder's Equity | 5,805 | 6,379 | 8,646 | 5,601 | 1,612 |
Total Common Equity | 3,537 | 4,383 | 6,243 | 3,869 | 978 |
Shares Outstanding | 95.30 | 103.90 | 102.40 | 91.10 | 61.60 |
Book Value Per Share | 37.12 | 42.19 | 60.97 | 42.47 | 15.88 |
Fiscal Year End for BeiGene, Ltd falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 2,593 | 2,793 | 3,186 | 3,186 | 3,526 |
Receivables | 529 | 435 | 358 | 309 | 299 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 443 | 447 | 416 | 317 | 321 |
Other Current Assets | 274 | 232 | 243 | 242 | 255 |
Total Current Assets | 3,839 | 3,908 | 4,203 | 4,054 | 4,401 |
Net Property & Equipment | 1,516 | 1,418 | 1,324 | 1,178 | 1,032 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 54 | 55 | 57 | 54 | 47 |
Deposits & Other Assets | 199 | 199 | 125 | 141 | 149 |
Total Assets | 5,712 | 5,668 | 5,805 | 5,525 | 5,729 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 852 | 827 | 0 | 329 | 421 |
Accounts Payable | 333 | 357 | 315 | 342 | 267 |
Current Portion Long-Term Debt | 0 | 0 | 688 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 647 | 569 | 694 | 506 | 455 |
Income Taxes Payable | 5 | 27 | 23 | 20 | 17 |
Other Current Liabilities | 85 | 82 | 68 | 64 | 222 |
Total Current Liabilities | 1,939 | 1,882 | 1,810 | 1,283 | 1,405 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 16 | 16 | 17 | 17 | 40 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 185 | 199 | 198 | 202 | 207 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 171 | 221 | 234 | 252 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 2,346 | 2,307 | 2,268 | 1,762 | 1,930 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 11,840 | 11,705 | 11,599 | 11,503 | 11,752 |
Retained Earnings | -8,334 | -8,213 | -7,962 | -7,595 | -7,810 |
Other Equity | -140 | -132 | -99 | -145 | -144 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 3,366 | 3,360 | 3,537 | 3,763 | 3,799 |
Total Liabilities & Shareholder's Equity | 5,712 | 5,668 | 5,805 | 5,525 | 5,729 |
Total Common Equity | 3,366 | 3,360 | 3,537 | 3,763 | 3,799 |
Shares Outstanding | 96.90 | 95.60 | 95.30 | 97.00 | 96.60 |
Book Value Per Share | 34.74 | 35.15 | 37.12 | 38.80 | 39.32 |